Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Applying New Evidence to Optimize Care in Advanced Prostate Cancer

Matthew R. Smith, MD, PhD
Released: October 8, 2020
Back Next


In this module, Matthew Smith, MD, PhD, provides an overview of current evidence on the optimal management of advanced prostate cancer. This educational activity also reviews treatment recommendations from a CCO online interactive treatment decision tool for prostate cancer. This tool allows you to enter your specific patient’s characteristics, then offers treatment recommendations from 5 experts in prostate cancer: Emmanuel S. Antonarakis, MB BCh; Tanya B. Dorff, MD; David I. Quinn, MBBS, PhD, FRACP, FACP; Michael Schweizer, MD; and Matthew R. Smith, MD, PhD. To access this tool, please click here.

The key points discussed in this module are illustrated with thumbnails from the accompanying downloadable PowerPoint slideset, which can be found here or downloaded by clicking any of the slide thumbnails in the module alongside the expert commentary.

Clinical Care Options plans to measure the educational impact of this activity. Several questions will be asked twice: once at the beginning of the activity, then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Back Next
Provided by the USF Health in partnership with Clinical Care Options.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Sanofi Genzyme Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings